Nathan Pennell, Professor at Cleveland Clinic, shared by Bristol Myers Squibb on LinkedIn, adding:
“Memories of my mom are always close to me, especially as we approach World Lung Cancer Day. I lost my mom and both of my maternal grandparents—to lung cancer. It’s one thing to see the devastation that the disease wreaks on patients and families and another to witness the harmful stigma that still looms large.
These experiences were part of my motivation to become a thoracic oncologist, and they continue to drive me as we scale our collective impact at BMS.
As I recently discussed with my colleague, Tania Small real progress starts with understanding, and it’s sustained by an unwavering commitment to giving every patient the empathy, care, and support they deserve.”
Quoting Bristol Myers Squibb:
“Lung cancer remains one of the most stigmatized diseases, despite affecting a broad and growing population of people who have never smoked or quit years ago.
Addressing that stigma is an important part of our work to advance care for patients with thoracic cancers. It’s reflected in our research efforts and in the partnerships we build with physicians who care for patients every day.
As we prepare to observe World Lung Cancer Day tomorrow, hear from our SVP and Head of Global Medical Oncology, Nathan Pennell as he shares his personal and professional perspectives on why confronting this stigma is critical to continued progress in treating the disease.
Watch the full conversation.”